Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03206762Not ApplicableCompleted

JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon

Role: lead

NCT01345188Phase 4Completed

Ranolazine in Ischemic Cardiomyopathy

Role: lead

NCT05284240Not ApplicableCompleted

Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries

Role: lead

NCT02730234Not ApplicableCompleted

JetStream Atherectomy for the Treatment of In-stent Restenosis

Role: lead

NCT01722877Not ApplicableCompleted

JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions

Role: lead

NCT01599078Not ApplicableUnknown

Local Delivery of Paclitaxel Via the TAPAS Catheter to Prevent Restenosis From Percutaneous Femoropopliteal Intervention

Role: lead

All 6 trials loaded